Literature DB >> 29694340

Possible role of hippocampal GPR55 in spatial learning and memory in rats.

Bruno A Marichal-Cancino1, Alfonso Fajardo-Valdez2, Alejandra E Ruiz-Contreras3, Mónica Méndez-Díaz2, Oscar Prospéro-García2.   

Abstract

Endocannabinoids (eCBs) are involved in the hippocampal mechanisms of spatial learning and memory in rats. Although eCBs exert many of their actions on spatial learning and memory via CB1 receptors, the putative cannabinoid receptor GPR55 (expressed in the hippocampus, cortex, forebrain, cerebellum and striatum) seems to be also involved. To investigate the potential role of GPR55 in spatial learning and memory, Wistar rats received bilateral infusions of lysophosphatidylinositol (LPI, GPR55‑agonist) into the hippocampus 5‑minutes before training‑phase in the Barnes‑maze (BM). This manipulation increased the use of serial navigation while preventing the learning of spatial navigation strategy and decreasing the use of random activity to find the escape‑tunnel in the BM. In contrast, CID16020046 (GPR55‑antagonist) increased the use of random activity at the expense of spatial and serial navigation strategies. Finally, CID16020046 significantly reduced the time spent in the target zone during a retention test. Our results suggest: (i) a potential role of GPR55 in developing navigation strategies; (ii) a prospective function for LPI acting in hippocampal CA1 (probably via GPR55) to perform a serial navigation strategy; and (iii) a potential role of GPR55 in the mechanisms involved in spatial memory (object placement memory).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29694340

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  6 in total

Review 1.  The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Jesús Chávez-Reyes; Gonzalo Allende; Paulino Barragán-Iglesias; Bruno A Marichal-Cancino
Journal:  Neurosci Bull       Date:  2021-07-24       Impact factor: 5.271

Review 2.  Advances in Neurobiology and Pharmacology of GPR12.

Authors:  Gonzalo Allende; Jesús Chávez-Reyes; Raquel Guerrero-Alba; Priscila Vázquez-León; Bruno A Marichal-Cancino
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

3.  Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer's Disease in a Preclinical Model: A Therapeutic Opportunity.

Authors:  Dina Medina-Vera; Cristina Rosell-Valle; Antonio J López-Gambero; Juan A Navarro; Emma N Zambrana-Infantes; Patricia Rivera; Luis J Santín; Juan Suarez; Fernando Rodríguez de Fonseca
Journal:  Biology (Basel)       Date:  2020-11-05

4.  Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats.

Authors:  Felipe Patricio; Eliud Morales Dávila; Aleidy Patricio-Martínez; Nayeli Arana Del Carmen; Isabel Martínez; José Aguilera; Jose Manuel Perez-Aguilar; Ilhuicamina Daniel Limón
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

Review 5.  Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.

Authors:  Md Ezazul Haque; In-Su Kim; Md Jakaria; Mahbuba Akther; Dong-Kug Choi
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

6.  CB1 Activity Drives the Selection of Navigational Strategies: A Behavioral and c-Fos Immunoreactivity Study.

Authors:  Daniela Laricchiuta; Francesca Balsamo; Carlo Fabrizio; Anna Panuccio; Andrea Termine; Laura Petrosini
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.